ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,572,000 | +53.1% | 36,386 | +2.0% | 0.05% | +22.0% |
| Q1 2020 | $1,027,000 | -55.6% | 35,680 | -2.2% | 0.04% | -43.1% |
| Q4 2019 | $2,314,000 | +128.4% | 36,475 | +1.4% | 0.07% | +105.7% |
| Q3 2019 | $1,013,000 | +12.4% | 35,965 | +5.8% | 0.04% | +6.1% |
| Q2 2019 | $901,000 | +43.7% | 33,988 | -0.5% | 0.03% | +37.5% |
| Q1 2019 | $627,000 | +62.0% | 34,173 | +9.8% | 0.02% | +41.2% |
| Q4 2018 | $387,000 | – | 31,127 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |